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Syphilis affects approximately 11 million people each year globally, and is the third most
prevalent sexually transmitted bacterial infection in the United States. Inability to indepen-
dently culture and genetically manipulate Treponema pallidum subsp. pallidum, the causa-
tive agent of this disease, has hindered our understanding of the molecular mechanisms of
syphilis pathogenesis. Here, we used the non-infectious and poorly adherent B314 strain of
the Lyme disease-causing spirochete, Borrelia burgdorferi, to express two variants of a
known fibronectin-binding adhesin, Tp0136, from T. pallidum SS14 and Nichols strains.
Using this surrogate system, we investigated the ability of Tp0136 in facilitating differential
binding to mammalian cell lines offering insight into the possible role of this virulence factor
in colonization of specific tissues by T. pallidum during infection.
Principal findings
Expression of Tp0136 could be detected on the surface of B. burgdorferi by indirect immu-
nofluorescence assay using sera from a secondary syphilis patient that does not react with
intact B314 spirochetes transformed with the empty vector. Increase in Tp0136-mediated
adherence of B314 strain to human epithelial HEK293 cells was observed with comparable
levels of binding exhibited by both Tp0136 alleles. Adherence of Tp0136-expressing B314
was highest to epithelial HEK293 and C6 glioma cells. Gain in binding of B314 strain
expressing Tp0136 to purified fibronectin and poor binding of these spirochetes to the fibro-
nectin-deficient cell line (HEp-2) indicated that Tp0136 interaction with this host receptor
plays an important role in spirochetal attachment to mammalian cells. Furthermore, preincu-
bation of these cell lines with fibronectin-binding peptide from Staphylococcus aureus FnbA-
2 protein significantly inhibited binding of B314 expressing Tp0136.
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Conclusions
Our results show that Tp0136 facilitates differential level of binding to cell lines representing
various host tissues, which highlights the importance of this protein in colonization of human
organs by T. pallidum and resulting syphilis pathogenesis.
Author summary
Syphilis is one of the most prevalent sexually transmitted infections that affect millions of
people around the world. The causative bacterium, Treponema pallidum subsp. pallidum,
can be transmitted from mother to fetus during maternal infection, resulting in adverse
pregnancy outcomes. Although timely treatment of syphilis is highly effective, untreated
infection causes late syphilis that affects virtually every organ and leads to serious clinical
manifestations. Therefore, syphilis remains a serious healthcare problem. T. pallidum can-
not be grown in laboratory using traditional methods, which has slowed the progress in
understanding this pathogen biology and pathogenesis. We employed a novel approach of
using a related bacterium, Borrelia burgdorferi, to express Tp0136 protein from two differ-
ent T. pallidum isolates to study the function of this protein. This strategy enabled us to
demonstrate the ability of this protein to bind to fibronectin and laminin receptors pres-
ent on the surface of various host cells. We showed that Tp0136 facilitates binding to only
those host cells that produce fibronectin. In addition, we found that Tp0136-mediated
binding is not equivalent in all host cell types, suggesting that the protein could help in
colonization of specific human organs and tissues during infection by T. pallidum.
Introduction
Although syphilis can be easily diagnosed and treated, 11 million new infections are estimated
to occur annually, contributing to a global prevalence of ~36 million cases [1–3]. Congenital
syphilis resulting from vertical transmission of the syphilis agent, Treponema pallidum subsp.
pallidum (T. pallidum), is also a significant global health issue because an estimated 1.4 million
pregnant women acquire syphilis every year. Congenital syphilis is a major cause of fetal loss,
stillbirth, or malformations in the newborns, particularly in low-income countries where most
cases occur. Evidence that symptomatic syphilis infection increases the risk of HIV transmis-
sion and acquisition [4] further emphasizes the magnitude of the threat posed to public health
by this organism, and the need to better understand the molecular basis of syphilis pathogene-
sis. A better understanding of T. pallidum pathogenesis could lead to development of new
approaches to control the spread of this infection.
T. pallidum is a slow growing bacterium and is considered the most virulent among the spe-
cies and subspecies that cause human treponematoses because it causes serious systemic dis-
ease [5]. Following infection, T. pallidum rapidly disseminates to distant tissues and organs via
the circulatory and lymphatic system in the early stages of the disease [6, 7]. In addition to
crossing the placenta to cause congenital infection, the syphilis spirochete is also capable of
passing through the blood-brain barrier, an event that can lead to the early and late neurologi-
cal manifestations of the disease. Although the sequence of the first T. pallidum genome greatly
helped in the identification of potential virulence factors of this pathogen, progress in the
understanding of the pathogenesis of syphilis is hindered by several limitations inherent to the
study of this microorganism. Such limitations include the inability to grow T. pallidum
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continuously in vitro in pure culture, thus making it extremely difficult to genetically manipu-
late this pathogen. A newly described tissue culture approach, in which T. pallidum is co-cul-
tured with Sf1Ep epidermal cells of cottontail rabbits [8], will likely open new possibilities for
physiological studies that haven’t been feasible until now. Another limitation of studying T.
pallidum is that its envelope is exceedingly fragile compared to more conventional Gram-nega-
tive organisms [9] due to the absence of lipopolysaccharide (LPS) in its outer membrane and a
very thin peptidoglycan layer that is only loosely associated to the outer membrane. Further-
more, T. pallidum outer membrane displays a very low density of proteins on its surface [10–
15]. Because genetic manipulation of T. pallidum is still not possible, investigators have started
using heterologous expression systems to better characterize the virulence factors of this spiro-
chete [16–19].
Attachment to host components is a crucial initial step in the pathogenesis of the extracellu-
lar pathogens like T. pallidum that facilitates establishment of infection and tissue colonization
[20, 21]. Although T. pallidum’s ability to adhere to a variety of host cell types was known since
the 70s [22], significant progress toward the identification and functional characterization of
T. pallidum adhesins has materialized only in the last two decades [16, 19, 23–27]. These inves-
tigations led to identification of several T. pallidum adhesins; including laminin- (Tp0751) and
fibronectin- (Tp0136, Tp0155, Tp0483) binding proteins. However, these studies mostly relied
on the use of recombinant soluble versions of these proteins to determine their receptors and
role in adhesion, an approach that does not account for the conformational differences from
their natural, outer membrane-associated counterpart and might also lack post-translational
modifications. To bypass this obstacle, surrogate systems have been adapted in several recent
studies to better define the role of adhesins. Thus, surrogate systems were used to investigate
the laminin-binding lipoprotein Tp0751 [17], and T. pallidum lipoprotein Tp0435 that facili-
tates host cell binding [16], although the cellular receptor for Tp0435 has yet to be identified.
Both of these studies employed the causative agent of Lyme disease, Borrelia burgdorferi (B.
burgdorferi), as a surrogate spirochete to enable gain-of-function approach. B. burgdorferi was
found to be an excellent heterologous system to examine localization of surface proteins and to
study functions of T. pallidum lipoproteins. T. pallidum and B. burgdorferi are structurally and
physiologically related spirochetes and they are suggested to process and present lipoproteins
in a similar manner [28, 29]. It is therefore expected that processing of the translated Tp0136
protein facilitated by B. burgdorferi type II signal peptidase is followed by lipidation of the
invariant cysteine residue in the lipobox, which becomes the first amino acid of the mature
lipoprotein. Furthermore, B. burgdorferi is particularly useful to study T. pallidum adhesins
because non-pathogenic and poorly adherent derivatives of this spirochete have been obtained
by long-term in vitro cultivation of the wild-type strains [16, 30, 31]. Additionally, expression
of the native T. pallidum genes in a related organism served as an alternative way to corrobo-
rate surface-exposure of these proteins, whose localization on the surface of T. pallidum is
notoriously difficult.
In this study, we used the poorly adherent B. burgdorferi B314 strain to further characterize
the role of T. pallidum Tp0136 adhesin. The role of this lipoprotein in fibronectin binding was
first demonstrated by Brinkman et al. [32], and subsequently confirmed by Ke and coworkers
[27], who evaluated the binding activity of different isoforms of Tp0136, known to be hetero-
geneous among T. pallidum isolates, to both tissue and plasma fibronectin. They concluded
that this protein preferentially binds the tissue form of fibronectin, irrespective of the Tp0136
variant tested in those experiments. Here we used the B. burgdorferi B314 strain to: (a) express
two allelic variants of Tp0136, (b) investigate the role of this protein in mediating adhesion to
various primate cell lines by attachment to fibronectin and potentially laminin, and (c) evalu-
ate Tp0136 likely contribution to T. pallidum colonization of different tissues.
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Materials and methods
Ethics statement
All mouse experiments were performed in accordance with the provisions of the Animal Wel-
fare Act, the Guide for the Care and Use of Laboratory Animals, and the PHS Policy on
Humane Care and Use of Laboratory Animals. Experiments were conducted under the proto-
col # 14011D0617 approved by the Rutgers Biomedical and Health Sciences IACUC.
Cloning of tp0136 gene for expression of recombinant Tp0136 and for
transformation of B. burgdorferi
High passage B. burgdorferi strain B314 [33, 34] was grown in BSKII medium containing 6%
rabbit serum at 33˚C. Genomic DNA from the T. pallidum SS14 and Seattle-Nichols strains
were used to amplify the tp0136 gene as previously reported [27] using the Sense: (5’- GGGG
TACCTCTATTACGAGAAGGAGCGGC) and Antisense: (5’- AGAGTCGACGCAGACAA
AACCCTCACGATT) primers with KpnI and SalI sites underlined. PCR products were cloned
into the TOPO-XL vector (Invitrogen) according to the manufacturer’s protocol. The ampli-
con included 686 nucleotides upstream of the Tp0136 ORF, containing the gene putative pro-
moter, and 460 nucleotides from the gene 3’-flanking region. After sequence confirmation (S1
Fig), the insert was sub-cloned using KpnI and SalI digestion into a B. burgdorferi shuttle vec-
tor pJSB175, encoding a codon-optimized firefly luciferase, and the plasmid was used for
transformation and plating of B. burgdorferi B314 strain, as previously described [16, 35, 36].
For expression of recombinant Tp0136, the tp0136 ORF without the first 48 nucleotides
encoding the first 16 amino acids was amplified using the primers; 5Tp0136-sol (5’- GGGGG
ATCCATGACGGTGGTGCGCGCGGT) with BamH1, and 3Tp0136-sol (5’- GGGAAGCT
TTTACTCGCGGTTCCAGGAGCACGT) with HindIII sites underlined and cloned in
pET30a vector containing a 6xHis tag at the amino-terminal end of the recombinant protein
to allow purification by affinity chromatography.
Expression and purification of recombinant Tp0136 from E. coli and
generation of anti-Tp0136 mouse antibodies
Polyhistidine-tagged Tp0136 (pET30a-tp0136) was expressed in E. coli BL21(pLysS) strain and
recombinant Tp0136 from Nichols strain purified with the Nickel-affinity purification kit.
Antibodies were raised against purified Tp0136 in female BALB/c mice using our previously
described protocol [37].
Expression of Tp0136 on the surface of B. burgdorferi B314 determined by
indirect Immunofluorescence assay (IFA)
For examination of protein expression in B. burgdorferi strains, about 1-2x 108 cells/ml were
centrifuged and washed three times with PBS containing 0.2% bovine serum albumin (PBS/
BSA) to remove growth medium components. IFA was conducted using bacteria centrifuged
over coverslips placed in 24-well plate as described previously [37]. Briefly, after fixation with
3% paraformaldehyde in PBS for 1h and blocking with PBS/5% BSA/5% heat-inactivated goat
serum at room temperature for 1h, a secondary syphilis patient serum (1:100 dilution), previ-
ously obtained from Dr. Arturo Centurion-Lara at the University of Washington, or anti-
Tp0136 (Nichols strain) mouse serum (also used at 1:100) was added and plate incubated for
1h at room temperature. Coverslips were washed three times with PBS for five minutes each at
room temperature, and subsequently incubated for 1h with 300μl of secondary anti-human or
anti-mouse secondary antibody conjugated with AlexaFluor 488 and FITC (ThermoFisher),
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respectively diluted 1:100. To detect all spirochetes present in the field of view of the micro-
scope, DNA was stained with 4’,6-diamidino-2-phenylindole (DAPI) after bacterial permeabi-
lization using cold methanol for 20 minutes. As a control to ensure that the spirochete
membrane integrity was preserved during the procedure, B. burgdorferi were labeled in parallel
for periplasmic flagella using a mouse anti-FlaB monoclonal antibody, provided by Dr. Errol
Fikrig at Yale University, and used at 1:50 dilution for 1h to detect the lack of staining in intact,
and reaction with the permeabilized bacteria. Anti-mouse secondary antibodies (1:100 dilu-
tion) conjugated with TRITC (ThermoFisher) were used for fluorescence labeling. After four
washes, coverslips were mounted onto slides, and examined using Apo-Plan TIRF objective in
Nikon 80i fluorescence microscope.
Mammalian cells cultures
All cell lines were grown in an environmentally controlled incubator at 37˚C in 5% CO2 atmo-
sphere. African green monkey kidney epithelial Vero, C6 (rat) glioma, human umbilical vein
endothelial cells (HUVEC) Ea.Hy926, and human embryonic kidney epithelial HEK293, and
human epithelial HEp-2 cell lines were originally provided by Dr. John Leong at Tufts Univer-
sity School of Medicine. C6 glioma cell line was grown in RPMI medium supplemented with
8% FBS and Penicillin/Streptomycin (P/S) mixture, while HEK293 cells were cultivated in 1:1
mixture of Dulbecco’s Modified Eagle’s Medium (DMEM) and Ham’s F12 medium supple-
mented with 10% FBS and P/S mixture. Vero cells as well as HEp-2 cells were grown on RPMI
medium supplemented with 10% NuSerum (ThermoFisher) and P/S mixture. Human placen-
tal fibroblast BeWo cells (ATCC1 CCL-98™) were cultured in F-12K medium supplemented
with 10% FBS and P/S mixture and Ea.Hy926 cells were grown in DMEM medium with 1%
HAT, 10% FBS and P/S mixture.
Binding of radiolabeled B. burgdorferi to mammalian cells
To assess adherence, transformed B. burgdorferi B314 strains were labeled with a 35S methionine-
cysteine mixture (Perkin-Elmer). Bacteria were harvested by centrifugation when culture density
reached approximately 5×107–1×108 spirochetes/ml. After three five-minute washes with PBS/
BSA to remove unbound label, bacterial pellets were resuspended in BSK-H medium without
serum but supplemented with sterile glycerol (20% final concentration) and 1ml aliquots of
labeled B. burgdorferi containing 1-2x108 spirochetes per ml were stored at -80˚C until use.
Binding assays were conducted using B. burgdorferi and mammalian cell lines as previously
published [37, 38]. Briefly, cell cultures were plated in Nunc break-apart 96 well plates and
allowed to grow for at least 24h to form a confluent monolayer. After quick thawing, B314
transformed with the shuttle vector alone and the vector containing the Tp0136 variants,
respectively were centrifuged, resuspended in BSK-H and left at room temperature for two
hours to recover physiologically as indicated by regaining of vigorous motility. Glucose
(10mM)-HEPES (10mM, pH 7.0)-Salt (50mM) or GHS was added to obtain 2:1 ratio of GHS
with bacterial suspension in BSK-H and spirochetes were incubated for an additional hour at
room temperature. To determine the input bacterial count, 50μl of each culture suspension
(~1x106 spirochetes) were filtered through Corning Costar Spin-X centrifuge tube filters. After
washing the filter with PBS and drying, radiolabel was measured using an LS 650 Multi-Pur-
pose Scintillation Counter (Beckman Coulter). For binding determination by transfected B.
burgdorferi, cell lines were washed twice with PBS, and then 50μl of each bacterial suspension
containing ~1x106 spirochetes were added to quadruplicate wells containing each cell line.
Empty wells were also included as “no cell” controls for each treatment. After an hour of incu-
bation at room temperature while rocking, wells were washed three times with PBS/BSA to
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remove unbound bacteria and plates were left to air dry. Each plate well was broken and placed
in scintillation vial and 2ml Opti-Fluor O (Perkin Elmer) was added per vial. Radiolabel in
each well was measured as described above. Average count obtained from four empty wells
(without any bacteria or cells) was deducted from radiolabel count obtained from each well of
the plate to obtain net count per well. Percent binding by the transformed B314 clone in each
well was calculated using total input count for the respective clone determined as described
above. Thus percent binding = (Net count per well/total input count) x100.
Binding of radiolabeled B. burgdorferi to fibronectin and laminin
Stocks of human foreskin fibroblast fibronectin and laminin (Sigma-Aldrich) were diluted in
PBS and 50μl of suspension containing 1μg of each protein was used to coat wells of a Nunc
break-apart 96 well plate by incubation at 37˚C for 3h. The plates were then stored at 4˚C until
use. After washing three times with PBS, plates were incubated at room temperature with
blocking buffer containing 1% BSA in PBS for 30 minutes. After removal of blocking buffer,
wells were incubated with 50μl of each labeled bacterial strain, as described above. After 1h
incubation at room temperature while rocking, plates were washed and the level of bound
labeled bacteria measured by scintillation counting as described above.
Binding of fibronectin and laminin to B. burgdorferi expressing Tp0136
For examination of fibronectin and laminin binding to B. burgdorferi strains expressing allelic
variants of Tp0136, bacteria were washed twice with the PBS/BSA buffer and then centrifuged
on coverslips as described for IFA above. B. burgdorferi strains were incubated with 1.5μg of
fibronectin or laminin suspended in 300μl PBS/BSA buffer for one hour at room temperature.
After three washes for five minutes each at room temperature with PBS while shaking, 300μl of
anti-fibronectin monoclonal antibody labeled with AlexaFluor 488, or anti-laminin polyclonal
antibody-labeled with DyLight 550 (Thermo Fisher) diluted 1:100 in PBS/BSA were added to
the respective coverslips. To detect all bacteria in each microscopic field, DNA staining was
performed with DAPI after permeabilization with methanol as described for IFA above. After
four washes coverslips were mounted onto slides and examined using an OLYMPUS BX61
fluorescent microscope, and images captured using the OLYMPUS CellSens Dimension 2.1
software (Olympus Corporation, Japan).
Inhibition of binding to fibronectin, C6 and HEK293 cells by fibronectin
binding peptide
FnbA-2 fibronectin-binding peptide from Staphylococcus aureus protein (Thermo Fisher) was
used to inhibit binding of radiolabeled transformed B314 to fibronectin alone, and to HEK293
and C6 Glioma cells. Fifty microliters of PBS or DMEM (Mock for fibronectin binding and
cell binding) or 200μg/ml of peptide diluted either in PBS for fibronectin-coated wells, or in
DMEM for the cell lines, were added (10μg/well) and plate incubated for one hour at room
temperature while rocking to allow peptide binding to immobilized fibronectin or cell mono-
layers. After two washings with PBS to remove unbound peptide, 50μl of radiolabeled bacteria
were added to each well. After incubation for 1h while rocking at room temperature, plates
were washed and dried followed by scintillation counting as described above.
Statistical analyses
All statistical analyses were conducted using GraphPad Prism version 8.0, Software (La Jolla,
CA). Data are presented as mean ± standard deviation (SD). Comparisons in binding between
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allelic variants of Tp0136 or among the same variant but different cell type, fibronectin and
laminin was performed using unpaired student t-test for unequal variance to determine signif-
icant differences between paired groups. ANOVA was used to compare binding of both allelic
variants of Tp0136 to various cell types or to fibronectin and laminin, and p values below 0.05
at 95% confidence interval to determine difference between groups were considered statisti-
cally significant.
Results
Comparison of Tp0136 sequences from the Nichols and SS14 strains of T.
pallidum
The sequence of T. pallidum Tp0136 variants inserted into the pJSB175 plasmid and the trans-
lated tp0136 ORFs are shown (S1 Fig). The proposed primary fibronectin-binding region of
Tp0136 [27] is marked in the protein sequence that shows some variation between two alleles.
Structural prediction and modeling of Tp0136
Predicted secondary and tertiary structural representation of the best-fit model of full Tp0136
translated ORF, based upon the highest C- and TM scores among 10 threading templates,
determined by the I-TASSER server [39–41], showed β strand rich domains (S2 Fig).
Expression and localization of Tp0136 variants on B. burgdorferi surface
IFA using a secondary syphilis serum showed surface punctate labeling (green) only on B314
strains expressing the Tp0136 variants (b and c in second row of Fig 1; SS14 and Nichols) but
not on B314 transformed with an empty vector used as a control (V; a in second row of Fig 1).
Thus, the antiserum specifically recognized Tp0136 localized on the surface of B314 strain,
and not the surface proteins of B. burgdorferi strain used in this study. Similar intensity of
staining of Tp0136 from Nichols and SS14 strains of T. pallidum was detected on B314 surface
(b versus c in second row of Fig 1). The absence of flagellar FlaB staining (row 4 of Fig 1) unless
the spirochetes were permeabilized (row 6 of Fig 1) with methanol indicated that the integrity
of the outer membrane was maintained during the assay. Similar results were also obtained in
IFA using anti-Tp0136 antibodies raised in mice confirming these findings (S3 Fig); however,
low titer antibodies generated in mice against Tp0136 did not label Tp0136 as intensely as the
selected secondary syphilis patient serum.
B314 expressing Tp0136 is able to bind to fibronectin-producing epithelial
cell lines
Binding of T. pallidum to the epithelium plays a critical role in initiating primary syphilitic
lesions. Investigation of Tp0136-mediated adherence of otherwise poorly adherent B. burgdor-
feri B314 strain to two epithelial cell lines (Vero and HEK293) showed a significant increase in
binding to Vero and HEK293 cells compared to the B314 control strain with vector alone (V;
Fig 2) and was also significantly higher than the wells with no cells. Both Tp0136 variants
induced similar binding levels to Vero cells (Fig 2). Binding of Tp0136-expressing B314 strains
to HEK293 cells was significantly higher than to Vero cells. Although the SS14 Tp0136 protein
appeared to bind to HEK293 cells slightly less efficiently compared to the Nichols strain vari-
ant (Fig 2), this difference may not be of great consequence because similar level of binding is
observed by both Tp0136 alleles on all other cell lines (see below). Since Tp0136 is a fibronec-
tin-binding protein, we further examined binding of B314 containing both alleles to control
HEp-2 cell line, which is deficient in fibronectin production [42, 43]. Binding of all B314
Host cell binding by Tp0136 of Treponema pallidum
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recombinant strains to HEp-2 cells was not dissimilar from the “no cell” control wells (Fig 2)
supporting that fibronectin indeed is the main Tp0136 target on the other mammalian cell
lines examined here.
Tp0136-expressing B314 strains bind to placental, glioma, and endothelial
cell lines
Tp0136-mediated adherence of B314 surrogate strains was also analyzed using non-epithelial
cells lines. We selected cell lines that are representative of tissues that T. pallidum encounters
during disseminated infection. Thus, Ea.Hy926 cell line was used as a representative of endo-
thelial cells, BeWo cells to mimic placental epithelium, and C6 glioma cells as a non-neuronal
Fig 1. Expression of the two allelic variants of Tp0136 on B. burgdorferi strain B314 surface. Treatment of B314
strain expressing Tp0136 alleles from T. pallidum SS14 and Nichols strains with antiserum obtained from a secondary
syphilis (SS) patient followed by visualization using AlexaFluor-488 conjugated anti-human IgG antibodies showed
punctate green spirochetes surface staining (panels b and c in the 2nd row). The SS serum did not react with other
targets on the B. burgdorferi B314 control strain transformed with an empty shuttle vector (V) in the panel a in the 2nd
row. DNA staining by DAPI in the panels in rows 1, 3, and 5 show all bacteria present in the respective microscopic
fields. A monoclonal antibody against FlaB followed by TRITC-labeled secondary anti-mouse antibodies stained
spirochetes only after permeabilization with methanol (Permeabilized, panels a, b, and c in the 6th row) but not intact
spirochetes (Unpermeabilized, panels a, b, and c in the 4th row) showing that bacterial outer membrane remained
unperturbed during the IFA procedure. Bar represents 16 μm.
https://doi.org/10.1371/journal.pntd.0007401.g001
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representative of central nervous system (Fig 3). Tp0136-mediated adherence of transformed
B314 strains to all cell lines was significantly higher than the B314 vector control strain, with
highest adherence observed on C6 glioma cells (Fig 3). However, binding of these spirochetes
to placental and endothelial cells was moderate (~50% of the binding to C6 glioma cells; Fig 3).
Comparable binding of both Tp0136-expressing B314 strains to the BeWo and Ea.Hy926 cells
indicated that binding was not affected by Tp0136 sequence differences.
Fig 2. B. burgdorferi B314 strain expressing Tp0136 allelic variants bind to HEK293 more efficiently than to Vero
cells but fail to adhere to HEp-2 cells. Average binding of radiolabeled B. burgdorferi B314 expressing Tp0136
variants of the SS14 and Nichols strains to Vero cells was 6% and 8%, respectively. Percent of binding mediated by
Nichols strain Tp0136 to HEK293 cells was significantly higher than binding by SS14 strain Tp0136. Both variants of
Tp0136 bound poorly to the HEp-2 cells, which do not produce fibronectin. Statistical analysis was conducted using a
two-tailed unpaired student t test for unequal variance to determine significant difference between the paired groups
and p values calculated (�p<0.05).
https://doi.org/10.1371/journal.pntd.0007401.g002
Fig 3. Tp0136 facilitated B314 binding to glioma, placental, and endothelial cell lines. Binding of B314 expressing
Tp0136 to placental (BeWo), glioma (C6), and endothelial (Ea.Hy926) cell lines were significantly higher compared to
B314 control strain. Allelic variants of the Tp0136 protein did not display significant differences in binding to any of
these three cell lines. Statistical analysis was conducted using a two-tailed unpaired student t test for unequal variance
to determine significant difference between the paired groups and p values calculated (�p<0.05, ��p<0.01, and
���p<0.001).
https://doi.org/10.1371/journal.pntd.0007401.g003
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Tp0136-expressing B. burgdorferi strains bind to human foreskin
fibronectin and laminin
Previous studies showed that Tp0136 binds to fibronectin and, less efficiently, to laminin [27,
32]. Binding of radiolabeled B314 strain expressing both variants of Tp0136 in native form to
purified fibronectin was significantly higher than the control B314 strain but did not differ
among Tp0136-expressing B314 strains (Fig 4). Tp0136 allele from SS14 strain mediated the
higher binding to laminin than protein from Nichols strain (Fig 4) with significant differences
observed among these alleles. Overall, in accordance to previous work using recombinant pro-
teins to study adherence mechanism, laminin binding mediated by Tp0136 expressed on spi-
rochete surface was also significantly lower than to fibronectin. We further analyzed binding
of fibronectin and laminin by using a complementary IFA-based test to allow visual observa-
tion using a fluorescent microscope. B314 spirochetes expressing either of the two Tp0136
alleles were able to bind tissue fibronectin (Fig 5). B314 expressing Tp0136 from both T. palli-
dum strains showed moderate but detectable binding by laminin, which was not detectable on
the control B314 strain (Fig 5) and was more intense on Tp0136 from the SS14 strain.
Inhibition of binding of Tp0136-expressing B314 to fibronectin and
mammalian cells by FnbA-2
We first determined if binding of Tp0136-expressing B314 strains to fibronectin can be inhib-
ited by preincubation with the fibronectin binding peptide of S. aureus FnbA-2 protein. As
expected, binding of B314 expressing different Tp0136 alleles to human fibronectin was signif-
icantly reduced when fibronectin immobilized in wells was preincubated with the FnbA-2
Fig 4. B314 expressing Tp0136 variants from Nichols and SS14 strains bind to human fibronectin and laminin.
Binding of Tp0136-expressing B314 to wells coated with human tissue fibronectin was significantly higher than that of
the control B314 (V) strain; however, binding facilitated by two alleles of Tp0136 was comparable to this ECM
component. Binding of B314 expressing the SS14 Tp0136 to laminin was significantly higher than B314 expressing the
Nichols variant. Statistical analysis was conducted using a two-tailed unpaired student t test for unequal variance to
determine significant difference between the paired groups and p values calculated (�p<0.05, ��p<0.01,
����p<0.0001).
https://doi.org/10.1371/journal.pntd.0007401.g004
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peptide (Fig 6A). Furthermore, to determine contribution of Tp0136-fibronectin interaction
on cell binding, we preincubated cell monolayers with the fibronectin-binding peptide and
quantitated B314 binding to HEK293 and C6 glioma cells by scintillation counting. We
selected these cell lines because adherence to these cells was significantly higher than other cell
lines we examined (Fig 2 and Fig 3). Reduction in binding of the spirochete derivatives by
FnbA-2 peptide on both HEK293 and C6 glioma cells indicated that Tp0136-fibronectin inter-
action is involved in adherence of spirochetes to these cells. Inhibition of adherence mediated
by both Tp0136 variants on HEK293 cells was significant with 18.8% and 26.3% reduction in
binding for the SS14 and Nichols strain variants, respectively (Fig 6B). Comparable inhibition
in binding of Tp0136 expressing B314 strains to C6 glioma cells was also observed with 25.3%
and 27.70% reduction for the SS14 and Nichols strain proteins, respectively (Fig 6C). Reduc-
tion in binding of control B314(V) strain by the peptide was not statistically significant.
Fig 5. Both purified tissue fibronectin and laminin bind to Tp0136 alleles expressed on B314 strain. Spirochetes
on coverglasses were incubated with purified tissue fibronectin or laminin and binding was detected using anti-
fibronectin (antiFn-FITC), 2nd row from top, and anti-laminin (DyLight 410) using YFP filter (antiLm-YFP)
antibodies, bottom row. DAPI stained DNA in B314 transformants depict all spirochetes present in the respective
microscopic fields. Top row shows all spirochetes in the field of view depicting fibronectin binding (2nd row) while 3rd
row shows all transformed B314 in the field of view showing laminin binding (bottom row). Both allelic variants of
Tp0136 showed similar efficiency in binding to fibronectin. Overall, binding of laminin to both Tp0136-expressing
strains was observed with more pronounced binding to B314 expressing the SS14 Tp0136, compared to the strain
expressing the Nichols variant. No laminin binding to B314(V) control was detected. Bars represent 16 μm.
https://doi.org/10.1371/journal.pntd.0007401.g005
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Discussion
Syphilis is a chronic and systemic disease, caused by the spirochete T. pallidum. It is primarily
transmitted either through sexual contact or by vertical, transplacental migration, resulting in
congenital syphilis [9, 44, 45]. Due to the known limitation of working with this pathogen,
investigators have heavily relied on comparative genomics to identify putative-surface-exposed
virulence factors of this pathogen. [46, 47]. The newly described co-culture system for T. palli-
dum [8] will possibly be the gateway to genetically engineer the syphilis agent but, for the time
being, manipulation of T. pallidum is still not feasible. Consequently, functional analysis of
possible virulence factors using knockout T. pallidum mutants is still not an option. A recent
approach adapted by several researchers to perform gain-of-function studies used B. burgdor-
feri as a surrogate spirochete. This system enabled investigation of the adherence mechanisms
of T. pallidum to host cells, which is a critical step in the pathogenesis of this extracellular path-
ogen [16, 17]. This heterologous expression system also offers the advantage of eliminating
interference from T. pallidum proteins with redundant functions [23, 24, 26, 27], and thus also
facilitates result interpretation unambiguously. Previous recombinant protein-based assays
suggested that a surface-exposed Tp0136 lipoprotein of T. pallidum that exhibits inter-strain
allelic variability contributes to tissue colonization by binding to cellular and plasma fibronec-
tin. Previous studies also showed that the TP0136 amino (N)-terminal region is primarily
responsible for binding to plasma fibronectin, but that binding sites for cellular fibronectin are
also present in the protein’s central and carboxyl (C)-terminal regions [27, 32].
The current study was undertaken to confirm Tp0136 surface exposure when the protein is
expressed in a poorly adherent B. burgdorferi surrogate strain and to further confirm its func-
tion in its close to normal conformation. The possibility that lipoproteins gain surface-expo-
sure in T. pallidum is in fact a fairly new finding that is still amply debated, even though
evidence toward that direction is mounting [16, 48]. Bacterial lipoproteins are expected to con-
tain amino-terminal cysteine (+1 position of the mature protein) with lipid modification.
Fig 6. Fibronectin binding peptide FnbA-2 of S. aureus reduces attachment of Tp0136 –expressing B314 strain to
purified fibronectin, and to C6 glioma and HEK293 cell lines. (A) Significant reduction in binding of both Tp0136
variants to immobilized tissue fibronectin was observed upon preincubation of fibronectin with FnbA-2 (light color
bars) as compared to the mock treated samples (buffer only treatment, dark color bars). (B) Significant reduction in
binding of both Tp0136 alleles expressing B314 to HEK293 cells by the FnbA-2 peptide was detected as marked by
underlined numbers above the bars; however, binding mediated by two Tp0136 alleles was not significantly different
on these cells (p = 0.748). (C) Significant inhibition of binding to C6 glioma cells by the FnbA-2 peptide was also
observed. Percent inhibition of binding by FnbA-2 peptide is indicated by the underlined numbers above the bars.
Statistical analysis was conducted using a two-tailed unpaired student t test for unequal variance to determine
significant difference between the paired groups and p values calculated (NS-not significant, �p<0.05, ��p<0.01,
���p<0.001).
https://doi.org/10.1371/journal.pntd.0007401.g006
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Based upon sequence analysis of Tp0136, it is difficult to determine identity of the first cysteine
of the mature lipoprotein with certainty. According to SpLip predictions, spirochete
lipobox consists of five amino acids at the carboxyl-terminal end of the signal peptide that is
cleaved by a signal peptidase II. Its characteristics are that Ala, Gly, Ser, Asn or Cys are allowed
at the -1 position, while Leu, Ile, Val and Phe should be present at positions -3 and/or -4.
Charged amino acids like Lys, Arg, His, Asp, and Glu are prohibited in the lipobox [29]. This
suggests that the likely lipobox for the mature Tp0136 is LLTTC (AA 30–34) is the target of sig-
nal peptidase II, although this model does not completely fits the above criteria for the -1 posi-
tion (S1 Fig). Predicted model of Tp0136 using I-TASSER server showed primarily β-strand
rich domains (S2 Fig). Crystal structures of other lipoproteins of spirochetes with several β-
strands rich domains have also been shown previously [49–52].
We demonstrated that the expression of two distinct allelic variants of Tp0136 on the surface
of B. burgdorferi B314 strain is similar (Fig 1). Moreover, both secondary syphilis patient and
mouse sera antibodies recognized Tp0136 allelic isoforms and did not label B. burgdorferi sur-
face in a non-specific way. Also, as already known [16, 17, 48], our study shows that Tp0136
expressed on the surface of the surrogate spirochete increases binding to tissue fibronectin
more than to laminin (Figs 4 and 5). Collectively, these results indicate that when B. burgdorferi
is used as a heterologous surrogate system to express surface proteins of T. pallidum, it correctly
sorts them to their natural cellular compartment, allowing gain-of-function approach feasibility.
Infectious B. burgdorferi possesses at least two fibronectin-binding proteins, BBK32 and
BB0347. An endogenous plasmid-borne gene encodes BBK32 while the bb0347 gene is located
on the chromosome [42, 53–55]. Although B314 strain has lost the endogenous plasmid carry-
ing the bbk32 gene [56], binding of the control B314 strain (transformed with the empty shuttle
vector) can be attributed to the low level expression of BB0347 [57]. With such premises, the dif-
ferences seen when using Tp0136-expressing strains can be attributed primarily to the fibronec-
tin/laminin-binding protein of the syphilis spirochete. The Nichols and SS14 variants (S1 Fig)
of Tp0136 show nearly 90% identity and 92% similarity, with differences spread almost evenly
throughout the length of the protein. According to the results of the binding experiments, these
differences do not appear to play a significant role in determining Tp0136 binding efficiency to
purified fibronectin (Figs 4 and 5), and to mammalian cells (Figs 2 and 3).
High level of binding to HEK293 cells and not to Vero cells, which are also epithelial cells,
might simply reflect differences in the levels of fibronectin and/or laminin expression in these
cell lines. Nonetheless, the lack of binding to the HEp-2 cells, which is deficient in producing
fibronectin [42, 43], is a clear indicator of the importance of fibronectin-Tp0136 interaction
for T. pallidum adhesion to host cell components (Fig 2). The difference in binding mediated
by SS14 strain Tp0136 compared to that of Nichols strain Tp0136 to HEK293 cells, and better
recognition of laminin by SS14 Tp0136 (Figs 4 and 5), suggest that allelic differences could
play a moderate role in attachment to different cells during infection, as mediated by differen-
tial levels of expression of the receptor(s). Relatively lower levels of adherence to human pla-
cental and endothelial cells (Fig 3) compared to HEK 293 cells further supports the premise
that Tp0136 of T. pallidum could play a role in differential cell binding-mediated colonization
of different tissues during infection, which could be potentially again be attributed to the levels
of fibronectin and laminin present on the specific host cell surface. High levels of binding of
B314 expressing different Tp0136 variants to C6 glioma cells (Fig 3) suggest importance of this
protein in tropism of T. pallidum to cells associated with nervous system. Overall, our results
indicate that Tp0136 may contribute to colonization of tissues during infection by recognition
of these target proteins.
Although inhibition of adherence to purified receptors and host cells by the specific anti-
bodies have been used for different pathogens, we decided not to use inhibition of bacterial
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binding by the specific antibodies. This is because in our (N.P.) extensive experience in study-
ing adherence of difference spirochetes to host cells [37, 38, 58–61], we have found that; (a) in
many cases antibodies are bactericidal or affect integrity of the spirochetes [38, 62–67], (b)
antibodies can facilitate formation of spirochete clumps that could interfere in proper binding
of bacteria, and (c) antibodies can exaggerate reduction in binding by steric inhibition due to
their large size. The last two points are also applicable when preincubation of the spirochetes
with purified fibronectin is used for inhibition of binding of bacteria to the host cells. There-
fore, we decided to use the S. aureus FnbA-2 peptide as inhibitor of adherence. We observed a
significant inhibition in attachment of Tp0136-expressing B314 strains to fibronectin, and
HEK293 and C6 glioma cells when they were preincubated with FnbA-2 (Fig 6). Interestingly,
fibronectin binding to Tp0136 also shows significant staining in IFA (Fig 5) suggesting its cor-
relation with the ability of FnbA-2 peptide to block interaction of Tp0136 with fibronectin
present on the host cells.
Tp0136 allelic variability could have evolved as a way to generate surface antigenic diversity
among T. pallidum strains as a general mechanism to facilitate immune evasion while main-
taining its basic function of adherence to the host cells. However, allelic variants of Tp0136 do
not seem to be drive significant differences in binding to cells, albeit both show specific affinity
for some cell types. In summary, our results show that Tp0136 mediates differential adherence
specificity to cell lines derived from different tissues, likely dependent on the level of fibronec-
tin and/or laminin produced by these cells, and reiterate the notion of a role for this virulence
factor in helping the syphilis agent to colonize various tissues.
Supporting information
S1 Fig. Comparison of the sequence from Treponema pallidum SS14 and Nichols strain.
(A) DNA insert containing tp0136 gene (blue) and upstream and downstream sequence
(orange) in Borrelia burgdorferi shuttle vector, and (B) Tp0136 Open Reading Frame (ORF)
with marked early cysteine residues (red), lipobox (bold blue underlined with putative first
cysteine residue of mature lipoprotein marked red) and putative fibronectin binding region
(blue).
(DOCX)
S2 Fig. Structural prediction of Tp0136 protein of Nichols and SS14 strains of T. pallidum
using I-TASSER server. (A). Amino Acid sequence and predicted secondary structure of
Tp0136 proteins determined by the I-TASSER server. The signal peptide sequence is in green
and the putative first cysteine residue of the mature Tp0136 lipoprotein is in purple and under-
lined. (B) Three-dimensional representation of the best-fit model of Tp0136 proteins (Nichols
and SS14 strains) based upon the highest C, and TM scores using 10 threading templates.
White arrow marks the helical domain of the signal peptide of Tp0136 while gray marked
region depicts predicted fibronectin binding domains.
(TIF)
S3 Fig. IFA depicting surface labeling of Tp0136 on B314 surface using anti-Tp0136
mouse serum. Low antibody titer polyclonal antibodies generated against recombinant
Tp0136 in Balb/c mice did not label control B314 containing the empty vector, i.e., B314(V),
and weakly reacted with the SS14 and Nichols Tp0136 expressed on B314 strain surface (bot-
tom row). Anti-mouse FITC-conjugated secondary antibodies marked the spirochetes green.
All spirochetes present in the microscopic fields, with DNA stained with DAPI, are shown in
the top row. Bar represents 16 μm.
(TIF)
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